Search research articles
Contact Us
Filters
Showing results (121-130 of 187) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
June 28, 2013
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas
Fredrick Hagemeister, Maria Alma Rodriguez, Steven R Deitcher, et al.
Blood Advances
|
January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Reem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
The Journal of Infectious Diseases
|
October 21, 2006
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma
Amar Safdar, M Alma Rodriguez, Luis E Fayad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
Sameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Leukemia & Lymphoma
|
November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
British Journal of Haematology
|
April 2, 2015
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
Felipe Samaniego, Fredrick Hagemeister, Jorge E Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2004
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma
Nam H Dang, Fredrick B Hagemeister, Barbara Pro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma
Neha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
British Journal of Haematology
|
January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 187) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
June 28, 2013
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas
Fredrick Hagemeister, Maria Alma Rodriguez, Steven R Deitcher, et al.
Blood Advances
|
January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Reem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
The Journal of Infectious Diseases
|
October 21, 2006
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma
Amar Safdar, M Alma Rodriguez, Luis E Fayad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
Sameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Leukemia & Lymphoma
|
November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
British Journal of Haematology
|
April 2, 2015
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
Felipe Samaniego, Fredrick Hagemeister, Jorge E Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2004
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma
Nam H Dang, Fredrick B Hagemeister, Barbara Pro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma
Neha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
British Journal of Haematology
|
January 4, 2014
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
Carlo Messina, Andrés J M Ferreri, Silvia Govi, et al.
Page
of 19